Clinical Trials Browser

Unknown × sintilimab × Tumor-Agnostic × Clear all

NCT04400851 2020-09-03

Sintilimab in the Treatment of Advanced and Refractory Pediatric Malignant Tumors

Phase 1 Unknown

Neoplasms

NCT04202601 2019-12-19

Efficacy and Safety Evaluation of Sintilimab in Combination With IBI310 as Treatment in Patients With EBV-Positive Gastric Cancer

Phase 1/2 Unknown

Adenocarcinoma